What is CAGE Code 5UTL7?

5UTL7 is the unique identifier used by NATO Organizations to reference the physical entity known as Catalyst Pharmaceuticals, Inc located at 355 Alhambra Cir Ste 801, Coral Gables FL 33134-5075, United States.

Who is CAGE Code 5UTL7?

5UTL7 refers to Catalyst Pharmaceuticals, Inc located at 355 Alhambra Cir Ste 801, Coral Gables FL 33134-5075, United States.

Where is CAGE Code 5UTL7 Located?

CAGE Code 5UTL7 is located in Coral Gables, FL, USA.

How Many NSNs Does CAGE Code 5UTL7 Supply?

CAGE Code 5UTL7 has been assigned as an approved source for 1 NSNs (National Stock Numbers and NATO Stock Numbers).

Catalyst Pharmaceuticals, Inc

CAGE Code: 5UTL7

NCAGE Code: 5UTL7

Status: Active

Type: Commercial Supplier

Dun & Bradstreet (DUNS): 053742248

Summary

Catalyst Pharmaceuticals, Inc is an Active Commercial Supplier with the Cage Code 5UTL7 and is tracked by Dun & Bradstreet under DUNS Number 053742248..

Address

355 Alhambra Cir Ste 801
Coral Gables FL 33134-5075
United States

Points of Contact

No Points of Contact...

Related Information

DUNS Report

People who viewed this 'CAGE Code' also viewed...

Frequently Asked Questions (FAQ) for CAGE 5UTL7

What is CAGE Code 5UTL7?: 5UTL7 is the unique identifier used by NATO Organizations to reference the physical entity known as Catalyst Pharmaceuticals, Inc located at 355 Alhambra Cir Ste 801, Coral Gables FL 33134-5075, United States.
Who is CAGE Code 5UTL7?: 5UTL7 refers to Catalyst Pharmaceuticals, Inc located at 355 Alhambra Cir Ste 801, Coral Gables FL 33134-5075, United States.
Where is CAGE Code 5UTL7 Located?: CAGE Code 5UTL7 is located in Coral Gables, FL, USA.
How Many NSNs Does CAGE Code 5UTL7 Supply?: CAGE Code 5UTL7 has been assigned as an approved source for 1 NSNs (National Stock Numbers and NATO Stock Numbers).

Contracting History for CAGE 5UTL7 Most Recent 25 Records

36C24524N0196
Amifampridine (Firdapse) 10Mg
6 Dec 2023: 245-Network Contract Office 5 (36C245); Department Of Veterans Affairs (Va); $16,928.97
36C26024F0017
Amifampridine Firdapse 10Mg Tab
2 Oct 2023: 260-Network Contract Office 20 (36C260); Department Of Veterans Affairs (Va); $203,147.64
36C24523N0425
Amifampridine (Firdapse) 10Mg
16 Mar 2023: 245-Network Contract Office 5 (36C245); Department Of Veterans Affairs (Va); $7,053.50
36C24523N0425
Amifampridine (Firdapse) 10Mg
21 Mar 2023: 245-Network Contract Office 5 (36C245); Department Of Veterans Affairs (Va); $34,394.25
36C26023F0042
Amifampridine (Firdapse) 10Mg Tab 120/Pkg Ndc: 69616-0211-06
21 Oct 2022: 260-Network Contract Office 20 (36C260); Department Of Veterans Affairs (Va); $187,752.00
36C24522N0740
Amifampridine (Firdapse) 10Mg
14 Sep 2022: 245-Network Contract Office 5 (36C245); Department Of Veterans Affairs (Va); $15,646.00
36C24522N0606
Amifampridine (Firdapse) 10Mg
9 Jul 2022: 245-Network Contract Office 5 (36C245); Department Of Veterans Affairs (Va); $15,646.00
36C26022F0038
E.O.14042 Amifampridine (Firdapse) 10Mg
9 Sep 2022: 260-Network Contract Office 20 (36C260); Department Of Veterans Affairs (Va); $154,859.62
36C26022F0038
E.O.14042 Amifampridine (Firdapse) 10Mg
29 Oct 2021: 260-Network Contract Office 20 (36C260); Department Of Veterans Affairs (Va); $154,859.62
36C26022F0038
E.O.14042 Amifampridine (Firdapse) 10Mg
28 Mar 2022: 260-Network Contract Office 20 (36C260); Department Of Veterans Affairs (Va); $154,859.62
HDTRA121P0012
Research And Development Services For Ind Filing Of 3,4-Diaminopyridine Phosphate.
22 Mar 2021: Defense Threat Reduction Agency; Department Of Defense (Dod); $86,650.00
HDTRA121P0012
Extend The Period Of Performance From 09/21/2021 To 01/31/2022.
21 Sep 2021: Defense Threat Reduction Agency; Department Of Defense (Dod); $86,650.00
HDTRA121P0012
Investigational New Drug Application (Ind) For The Purpose Of A Drug Repurposing Effort Of An Approved Drug, 3,4- Diaminopyridine Phosphate
16 Dec 2021: Defense Threat Reduction Agency; Department Of Defense (Dod); $86,650.00
HDTRA121P0012
Research And Development Services For A Investigational New Drug Application
28 Feb 2022: Defense Threat Reduction Agency; Department Of Defense (Dod); $86,650.00
HDTRA121P0012
Research And Development Services To Cross-Reference Existing Regulatory Communications And Submissions To Allow A Facile, Expedited Approval To Conduct Additional Preclinical Studies.
31 Jan 2022: Defense Threat Reduction Agency; Department Of Defense (Dod); $86,650.00
36E79719A0027
2021 Public Law Pricing Updates
23 Nov 2020: Nac Pharmaceuticals (36E797); Department Of Veterans Affairs (Va); $0.00
36E79719A0027
2024 Public Law Pricing Updates
15 Dec 2023: Nac Pharmaceuticals (36E797); Department Of Veterans Affairs (Va); $0.00
36C26022F0022
Amifampridine 10Mg Tab
1 Oct 2021: 260-Network Contract Office 20 (36C260); Department Of Veterans Affairs (Va); $29,691.62
36C24121F0084
Firdapse
17 Nov 2021: 241-Network Contract Office 01 (36C241); Department Of Veterans Affairs (Va); $29,916.56
36F79719D0160
Public Law Pricing Updates 2021 - Single Pricing
13 Nov 2020: Nac Federal Supply Schedule (36F797); Department Of Veterans Affairs (Va); $0.00
36F79719D029E
Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals,&Hematology Related Products
7 Feb 2019: Nac Federal Supply Schedule (36F797); Department Of Veterans Affairs (Va); $0.00
36F79719D029E
Interim Agreement -Cancellation
12 May 2019: Nac Federal Supply Schedule (36F797); Department Of Veterans Affairs (Va); $0.00
36E79719A0027
Exercise Option Year 2.
3 Jun 2021: Nac Pharmaceuticals (36E797); Department Of Veterans Affairs (Va); $0.00
36F79719D0160
2023 Public Law 102-585
16 Nov 2022: Nac Federal Supply Schedule (36F797); Department Of Veterans Affairs (Va); $0.00
36E79719A0027
Price Change On One Firdapse Ndc
5 Jun 2020: Nac Pharmaceuticals (36E797); Department Of Veterans Affairs (Va); $0.00

Supply Items Approved for CAGE 5UTL7 Page 1 of 1

6505-01-693-4057
Amifampridine Phosphate Tablets

FIRDAPSE: RNCC: 5 | RNVC: 1 | DAC: 4
NDC69616-0211-06: RNCC: 3 | RNVC: 2 | DAC: 4

10 Feb 2021